0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Atropine Market Research Report 2026
Published Date: 2026-02-11
|
Report Code: QYRE-Auto-18119
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Atropine Market Insights and Forecast to 2028
BUY CHAPTERS

Global Atropine Market Research Report 2026

Code: QYRE-Auto-18119
Report
2026-02-11
Pages:123
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Atropine Market Size

The global Atropine market was valued at US$ 477 million in 2025 and is anticipated to reach US$ 424 million by 2032, at a CAGR of -1.7% from 2026 to 2032.

Atropine Market

Atropine Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Atropine competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Atropine is a medication to treat certain types of nerve agent and pesticide poisonings as well as some types of slow heart rate and to decrease saliva production during surgery. It is typically given intravenously or by injection into a muscle. Eye drops are also available which are used to treat uveitis and early amblyopia. The intravenous solution usually begins working within a minute and lasts half an hour to an hour. Large doses may be required to treat some poisonings. Common side effects include a dry mouth, large pupils, urinary retention, constipation, and a fast heart rate. It should generally not be used in people with angle closure glaucoma. While there is no evidence that its use during pregnancy causes birth defects, it has not been well studied. It is likely safe during breastfeeding. It is an antimuscarinic (a type of anticholinergic) that works by inhibiting the parasympathetic nervous system. Atropine occurs naturally in a number of plants of the nightshade family including deadly nightshade, Jimson weed, and mandrake. It was first isolated in 1833. It is on the World Health Organization"s List of Essential Medicines, the most effective and safe medicines needed in a health system. It is available as a generic medication and is not very expensive.
Global Atropine key players include C²PHARMA, RESONANCE LABORATORIES, ROLABO OUTSOURCING, CR Double-Crane, Katsura Chemical, etc. Global top five manufacturers hold a share about 35%. China, Europe and North America is the largest market, each with a share about 25%, followed by Japan, with a share about 15 percent. In terms of product, Injection is the largest segment, with a share about 80%. And in terms of application, the largest application is Gastrointestinal, followed by Ophthalmology, etc.
This report delivers a comprehensive overview of the global Atropine market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Atropine. The Atropine market size, estimates, and forecasts are provided in terms of sales volume (Kg) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Atropine market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Atropine manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Atropine Market Report

Report Metric Details
Report Name Atropine Market
Accounted market size in 2025 US$ 477 million
Forecasted market size in 2032 US$ 424 million
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Injection
  • Drop
  • Gel
by Application
  • Gastrointestinal
  • Ophthalmology
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company C²PHARMA, RESONANCE LABORATORIES, ROLABO OUTSOURCING, Minsheng, CR Double-Crane, HENAN PURUI, Albany Molecular Research, Alchem International, SAURAV CHEMICALS, Katsura Chemical, Hangzhou Vega, Wuhan senwayer century
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Atropine manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Atropine sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

What is the Atropine Market size in 2032?

Ans: The Atropine Market size in 2032 will be US$ 424 million.

What is the market share of major companies in Atropine Market?

Ans: Global top five manufacturers hold a share about 35%.

What is the Atropine Market share by type?

Ans: In terms of product, Injection is the largest segment, with a share about 80%.

Who are the main players in the Atropine Market report?

Ans: The main players in the Atropine Market are C²PHARMA, RESONANCE LABORATORIES, ROLABO OUTSOURCING, Minsheng, CR Double-Crane, HENAN PURUI, Albany Molecular Research, Alchem International, SAURAV CHEMICALS, Katsura Chemical, Hangzhou Vega, Wuhan senwayer century

What are the Application segmentation covered in the Atropine Market report?

Ans: The Applications covered in the Atropine Market report are Gastrointestinal, Ophthalmology, Other

What are the Type segmentation covered in the Atropine Market report?

Ans: The Types covered in the Atropine Market report are Injection, Drop, Gel

1 Atropine Market Overview
1.1 Product Definition
1.2 Atropine by Type
1.2.1 Global Atropine Market Value by Type: 2025 vs 2032
1.2.2 Injection
1.2.3 Drop
1.2.4 Gel
1.3 Atropine by Application
1.3.1 Global Atropine Market Value by Application: 2025 vs 2032
1.3.2 Gastrointestinal
1.3.3 Ophthalmology
1.3.4 Other
1.4 Global Atropine Market Size Estimates and Forecasts
1.4.1 Global Atropine Revenue 2021–2032
1.4.2 Global Atropine Sales 2021–2032
1.4.3 Global Atropine Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Atropine Market Competition by Manufacturers
2.1 Global Atropine Sales Market Share by Manufacturers (2021–2026)
2.2 Global Atropine Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Atropine Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Atropine, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Atropine, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Atropine, Product Types and Applications
2.7 Global Key Manufacturers of Atropine, Date of Entry into the Industry
2.8 Global Atropine Market Competitive Situation and Trends
2.8.1 Global Atropine Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Atropine Players Market Share by Revenue
2.8.3 Global Atropine Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Atropine Market Scenario by Region
3.1 Global Atropine Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Atropine Sales by Region: 2021–2032
3.2.1 Global Atropine Sales by Region: 2021–2026
3.2.2 Global Atropine Sales by Region: 2027–2032
3.3 Global Atropine Revenue by Region: 2021–2032
3.3.1 Global Atropine Revenue by Region: 2021–2026
3.3.2 Global Atropine Revenue by Region: 2027–2032
3.4 North America Atropine Market Facts & Figures by Country
3.4.1 North America Atropine Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Atropine Sales by Country (2021–2032)
3.4.3 North America Atropine Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Atropine Market Facts & Figures by Country
3.5.1 Europe Atropine Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Atropine Sales by Country (2021–2032)
3.5.3 Europe Atropine Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Atropine Market Facts & Figures by Region
3.6.1 Asia Pacific Atropine Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Atropine Sales by Region (2021–2032)
3.6.3 Asia Pacific Atropine Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Atropine Market Facts & Figures by Country
3.7.1 Latin America Atropine Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Atropine Sales by Country (2021–2032)
3.7.3 Latin America Atropine Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Atropine Market Facts & Figures by Country
3.8.1 Middle East and Africa Atropine Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Atropine Sales by Country (2021–2032)
3.8.3 Middle East and Africa Atropine Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Atropine Sales by Type (2021–2032)
4.1.1 Global Atropine Sales by Type (2021–2026)
4.1.2 Global Atropine Sales by Type (2027–2032)
4.1.3 Global Atropine Sales Market Share by Type (2021–2032)
4.2 Global Atropine Revenue by Type (2021–2032)
4.2.1 Global Atropine Revenue by Type (2021–2026)
4.2.2 Global Atropine Revenue by Type (2027–2032)
4.2.3 Global Atropine Revenue Market Share by Type (2021–2032)
4.3 Global Atropine Price by Type (2021–2032)
5 Segment by Application
5.1 Global Atropine Sales by Application (2021–2032)
5.1.1 Global Atropine Sales by Application (2021–2026)
5.1.2 Global Atropine Sales by Application (2027–2032)
5.1.3 Global Atropine Sales Market Share by Application (2021–2032)
5.2 Global Atropine Revenue by Application (2021–2032)
5.2.1 Global Atropine Revenue by Application (2021–2026)
5.2.2 Global Atropine Revenue by Application (2027–2032)
5.2.3 Global Atropine Revenue Market Share by Application (2021–2032)
5.3 Global Atropine Price by Application (2021–2032)
6 Key Companies Profiled
6.1 C²PHARMA
6.1.1 C²PHARMA Company Information
6.1.2 C²PHARMA Description and Business Overview
6.1.3 C²PHARMA Atropine Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 C²PHARMA Atropine Product Portfolio
6.1.5 C²PHARMA Recent Developments/Updates
6.2 RESONANCE LABORATORIES
6.2.1 RESONANCE LABORATORIES Company Information
6.2.2 RESONANCE LABORATORIES Description and Business Overview
6.2.3 RESONANCE LABORATORIES Atropine Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 RESONANCE LABORATORIES Atropine Product Portfolio
6.2.5 RESONANCE LABORATORIES Recent Developments/Updates
6.3 ROLABO OUTSOURCING
6.3.1 ROLABO OUTSOURCING Company Information
6.3.2 ROLABO OUTSOURCING Description and Business Overview
6.3.3 ROLABO OUTSOURCING Atropine Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 ROLABO OUTSOURCING Atropine Product Portfolio
6.3.5 ROLABO OUTSOURCING Recent Developments/Updates
6.4 Minsheng
6.4.1 Minsheng Company Information
6.4.2 Minsheng Description and Business Overview
6.4.3 Minsheng Atropine Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Minsheng Atropine Product Portfolio
6.4.5 Minsheng Recent Developments/Updates
6.5 CR Double-Crane
6.5.1 CR Double-Crane Company Information
6.5.2 CR Double-Crane Description and Business Overview
6.5.3 CR Double-Crane Atropine Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 CR Double-Crane Atropine Product Portfolio
6.5.5 CR Double-Crane Recent Developments/Updates
6.6 HENAN PURUI
6.6.1 HENAN PURUI Company Information
6.6.2 HENAN PURUI Description and Business Overview
6.6.3 HENAN PURUI Atropine Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 HENAN PURUI Atropine Product Portfolio
6.6.5 HENAN PURUI Recent Developments/Updates
6.7 Albany Molecular Research
6.7.1 Albany Molecular Research Company Information
6.7.2 Albany Molecular Research Description and Business Overview
6.7.3 Albany Molecular Research Atropine Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Albany Molecular Research Atropine Product Portfolio
6.7.5 Albany Molecular Research Recent Developments/Updates
6.8 Alchem International
6.8.1 Alchem International Company Information
6.8.2 Alchem International Description and Business Overview
6.8.3 Alchem International Atropine Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Alchem International Atropine Product Portfolio
6.8.5 Alchem International Recent Developments/Updates
6.9 SAURAV CHEMICALS
6.9.1 SAURAV CHEMICALS Company Information
6.9.2 SAURAV CHEMICALS Description and Business Overview
6.9.3 SAURAV CHEMICALS Atropine Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 SAURAV CHEMICALS Atropine Product Portfolio
6.9.5 SAURAV CHEMICALS Recent Developments/Updates
6.10 Katsura Chemical
6.10.1 Katsura Chemical Company Information
6.10.2 Katsura Chemical Description and Business Overview
6.10.3 Katsura Chemical Atropine Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Katsura Chemical Atropine Product Portfolio
6.10.5 Katsura Chemical Recent Developments/Updates
6.11 Hangzhou Vega
6.11.1 Hangzhou Vega Company Information
6.11.2 Hangzhou Vega Description and Business Overview
6.11.3 Hangzhou Vega Atropine Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Hangzhou Vega Atropine Product Portfolio
6.11.5 Hangzhou Vega Recent Developments/Updates
6.12 Wuhan senwayer century
6.12.1 Wuhan senwayer century Company Information
6.12.2 Wuhan senwayer century Description and Business Overview
6.12.3 Wuhan senwayer century Atropine Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Wuhan senwayer century Atropine Product Portfolio
6.12.5 Wuhan senwayer century Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Atropine Industry Chain Analysis
7.2 Atropine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Atropine Production Mode & Process Analysis
7.4 Atropine Sales and Marketing
7.4.1 Atropine Sales Channels
7.4.2 Atropine Distributors
7.5 Atropine Customer Analysis
8 Atropine Market Dynamics
8.1 Atropine Industry Trends
8.2 Atropine Market Drivers
8.3 Atropine Market Challenges
8.4 Atropine Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Atropine Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Atropine Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Atropine Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Atropine Sales (Kg) of Key Manufacturers (2021–2026)
 Table 5. Global Atropine Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Atropine Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Atropine Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Atropine Average Price (USD/Kg) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Atropine, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Atropine, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Atropine, Product Types and Applications
 Table 12. Global Key Manufacturers of Atropine, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Atropine Companies by Tier (Tier 1, Tier 2, Tier 3), based on Atropine Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Atropine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Atropine Sales by Region (Kg), 2021–2026
 Table 18. Global Atropine Sales Market Share by Region (2021–2026)
 Table 19. Global Atropine Sales by Region (Kg), 2027–2032
 Table 20. Global Atropine Sales Market Share by Region (2027–2032)
 Table 21. Global Atropine Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Atropine Revenue Market Share by Region (2021–2026)
 Table 23. Global Atropine Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Atropine Revenue Market Share by Region (2027–2032)
 Table 25. North America Atropine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Atropine Sales by Country (Kg), 2021–2026
 Table 27. North America Atropine Sales by Country (Kg), 2027–2032
 Table 28. North America Atropine Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Atropine Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Atropine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Atropine Sales by Country (Kg), 2021–2026
 Table 32. Europe Atropine Sales by Country (Kg), 2027–2032
 Table 33. Europe Atropine Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Atropine Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Atropine Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Atropine Sales by Region (Kg), 2021–2026
 Table 37. Asia Pacific Atropine Sales by Region (Kg), 2027–2032
 Table 38. Asia Pacific Atropine Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Atropine Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Atropine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Atropine Sales by Country (Kg), 2021–2026
 Table 42. Latin America Atropine Sales by Country (Kg), 2027–2032
 Table 43. Latin America Atropine Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Atropine Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Atropine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Atropine Sales by Country (Kg), 2021–2026
 Table 47. Middle East and Africa Atropine Sales by Country (Kg), 2027–2032
 Table 48. Middle East and Africa Atropine Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Atropine Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Atropine Sales (Kg) by Type (2021–2026)
 Table 51. Global Atropine Sales (Kg) by Type (2027–2032)
 Table 52. Global Atropine Sales Market Share by Type (2021–2026)
 Table 53. Global Atropine Sales Market Share by Type (2027–2032)
 Table 54. Global Atropine Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Atropine Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Atropine Revenue Market Share by Type (2021–2026)
 Table 57. Global Atropine Revenue Market Share by Type (2027–2032)
 Table 58. Global Atropine Price (USD/Kg) by Type (2021–2026)
 Table 59. Global Atropine Price (USD/Kg) by Type (2027–2032)
 Table 60. Global Atropine Sales (Kg) by Application (2021–2026)
 Table 61. Global Atropine Sales (Kg) by Application (2027–2032)
 Table 62. Global Atropine Sales Market Share by Application (2021–2026)
 Table 63. Global Atropine Sales Market Share by Application (2027–2032)
 Table 64. Global Atropine Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Atropine Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Atropine Revenue Market Share by Application (2021–2026)
 Table 67. Global Atropine Revenue Market Share by Application (2027–2032)
 Table 68. Global Atropine Price (USD/Kg) by Application (2021–2026)
 Table 69. Global Atropine Price (USD/Kg) by Application (2027–2032)
 Table 70. C²PHARMA Company Information
 Table 71. C²PHARMA Description and Business Overview
 Table 72. C²PHARMA Atropine Sales (Kg), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
 Table 73. C²PHARMA Atropine Product
 Table 74. C²PHARMA Recent Developments/Updates
 Table 75. RESONANCE LABORATORIES Company Information
 Table 76. RESONANCE LABORATORIES Description and Business Overview
 Table 77. RESONANCE LABORATORIES Atropine Sales (Kg), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
 Table 78. RESONANCE LABORATORIES Atropine Product
 Table 79. RESONANCE LABORATORIES Recent Developments/Updates
 Table 80. ROLABO OUTSOURCING Company Information
 Table 81. ROLABO OUTSOURCING Description and Business Overview
 Table 82. ROLABO OUTSOURCING Atropine Sales (Kg), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
 Table 83. ROLABO OUTSOURCING Atropine Product
 Table 84. ROLABO OUTSOURCING Recent Developments/Updates
 Table 85. Minsheng Company Information
 Table 86. Minsheng Description and Business Overview
 Table 87. Minsheng Atropine Sales (Kg), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
 Table 88. Minsheng Atropine Product
 Table 89. Minsheng Recent Developments/Updates
 Table 90. CR Double-Crane Company Information
 Table 91. CR Double-Crane Description and Business Overview
 Table 92. CR Double-Crane Atropine Sales (Kg), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
 Table 93. CR Double-Crane Atropine Product
 Table 94. CR Double-Crane Recent Developments/Updates
 Table 95. HENAN PURUI Company Information
 Table 96. HENAN PURUI Description and Business Overview
 Table 97. HENAN PURUI Atropine Sales (Kg), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
 Table 98. HENAN PURUI Atropine Product
 Table 99. HENAN PURUI Recent Developments/Updates
 Table 100. Albany Molecular Research Company Information
 Table 101. Albany Molecular Research Description and Business Overview
 Table 102. Albany Molecular Research Atropine Sales (Kg), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
 Table 103. Albany Molecular Research Atropine Product
 Table 104. Albany Molecular Research Recent Developments/Updates
 Table 105. Alchem International Company Information
 Table 106. Alchem International Description and Business Overview
 Table 107. Alchem International Atropine Sales (Kg), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
 Table 108. Alchem International Atropine Product
 Table 109. Alchem International Recent Developments/Updates
 Table 110. SAURAV CHEMICALS Company Information
 Table 111. SAURAV CHEMICALS Description and Business Overview
 Table 112. SAURAV CHEMICALS Atropine Sales (Kg), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
 Table 113. SAURAV CHEMICALS Atropine Product
 Table 114. SAURAV CHEMICALS Recent Developments/Updates
 Table 115. Katsura Chemical Company Information
 Table 116. Katsura Chemical Description and Business Overview
 Table 117. Katsura Chemical Atropine Sales (Kg), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
 Table 118. Katsura Chemical Atropine Product
 Table 119. Katsura Chemical Recent Developments/Updates
 Table 120. Hangzhou Vega Company Information
 Table 121. Hangzhou Vega Description and Business Overview
 Table 122. Hangzhou Vega Atropine Sales (Kg), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
 Table 123. Hangzhou Vega Atropine Product
 Table 124. Hangzhou Vega Recent Developments/Updates
 Table 125. Wuhan senwayer century Company Information
 Table 126. Wuhan senwayer century Description and Business Overview
 Table 127. Wuhan senwayer century Atropine Sales (Kg), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
 Table 128. Wuhan senwayer century Atropine Product
 Table 129. Wuhan senwayer century Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Atropine Distributors List
 Table 133. Atropine Customers List
 Table 134. Atropine Market Trends
 Table 135. Atropine Market Drivers
 Table 136. Atropine Market Challenges
 Table 137. Atropine Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Atropine
 Figure 2. Global Atropine Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Atropine Market Share by Type: 2025 & 2032
 Figure 4. Injection Product Picture
 Figure 5. Drop Product Picture
 Figure 6. Gel Product Picture
 Figure 7. Global Atropine Market Value by Application (US$ Million), 2021–2032
 Figure 8. Global Atropine Market Share by Application: 2025 & 2032
 Figure 9. Gastrointestinal
 Figure 10. Ophthalmology
 Figure 11. Other
 Figure 12. Global Atropine Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Atropine Market Size (US$ Million), 2021–2032
 Figure 14. Global Atropine Sales (Kg), 2021–2032
 Figure 15. Global Atropine Average Price (USD/Kg), 2021–2032
 Figure 16. Atropine Report Years Considered
 Figure 17. Atropine Sales Share by Manufacturers in 2025
 Figure 18. Global Atropine Revenue Share by Manufacturers in 2025
 Figure 19. Top 5 and Top 10 Global Atropine Players: Market Share by Revenue in Atropine in 2025
 Figure 20. Atropine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 21. Global Atropine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 22. North America Atropine Sales Market Share by Country (2021–2032)
 Figure 23. North America Atropine Revenue Market Share by Country (2021–2032)
 Figure 24. U.S. Atropine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Canada Atropine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Europe Atropine Sales Market Share by Country (2021–2032)
 Figure 27. Europe Atropine Revenue Market Share by Country (2021–2032)
 Figure 28. Germany Atropine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. France Atropine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. U.K. Atropine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Italy Atropine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Russia Atropine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Asia Pacific Atropine Sales Market Share by Region (2021–2032)
 Figure 34. Asia Pacific Atropine Revenue Market Share by Region (2021–2032)
 Figure 35. China Atropine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Japan Atropine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. South Korea Atropine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. India Atropine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Australia Atropine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Taiwan Atropine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Indonesia Atropine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Thailand Atropine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Malaysia Atropine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Philippines Atropine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Latin America Atropine Sales Market Share by Country (2021–2032)
 Figure 46. Latin America Atropine Revenue Market Share by Country (2021–2032)
 Figure 47. Mexico Atropine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Brazil Atropine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Argentina Atropine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Middle East and Africa Atropine Sales Market Share by Country (2021–2032)
 Figure 51. Middle East and Africa Atropine Revenue Market Share by Country (2021–2032)
 Figure 52. Turkey Atropine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Saudi Arabia Atropine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. U.A.E Atropine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 55. Global Sales Market Share of Atropine by Type (2021–2032)
 Figure 56. Global Revenue Market Share of Atropine by Type (2021–2032)
 Figure 57. Global Atropine Price (USD/Kg) by Type (2021–2032)
 Figure 58. Global Sales Market Share of Atropine by Application (2021–2032)
 Figure 59. Global Revenue Market Share of Atropine by Application (2021–2032)
 Figure 60. Global Atropine Price (USD/Kg) by Application (2021–2032)
 Figure 61. Atropine Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String